YTHDC2 and gastric adenocarcinoma: As shown in Figure S3, YTHDC2 expression was significantly correlated with molecular subtypes in ACC, BRCA, COAD, HNSC, LGG, pheochromocytoma and paraganglioma (PCPG), PRAD, stomach adenocarcinoma (STAD) and UCEC.